Your browser doesn't support javascript.
loading
Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
Gangaplara, Arunakumar; Martens, Craig; Dahlstrom, Eric; Metidji, Amina; Gokhale, Ameya S; Glass, Deborah D; Lopez-Ocasio, Maria; Baur, Rachel; Kanakabandi, Kishore; Porcella, Stephen F; Shevach, Ethan M.
Affiliation
  • Gangaplara A; Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Martens C; Genomics Unit, Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States of America.
  • Dahlstrom E; Genomics Unit, Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States of America.
  • Metidji A; Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Gokhale AS; The Francis Crick Institute, London, United Kingdom.
  • Glass DD; Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Lopez-Ocasio M; Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Baur R; Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Kanakabandi K; Genomics Unit, Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States of America.
  • Porcella SF; Genomics Unit, Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States of America.
  • Shevach EM; Genomics Unit, Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States of America.
PLoS Pathog ; 14(4): e1006985, 2018 04.
Article in En | MEDLINE | ID: mdl-29672594

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Interferon Type I / T-Lymphocytes, Regulatory / Colonic Neoplasms / Arenaviridae Infections / Tumor Microenvironment / Lymphocytic Choriomeningitis Language: En Journal: PLoS Pathog Year: 2018 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Interferon Type I / T-Lymphocytes, Regulatory / Colonic Neoplasms / Arenaviridae Infections / Tumor Microenvironment / Lymphocytic Choriomeningitis Language: En Journal: PLoS Pathog Year: 2018 Type: Article Affiliation country: United States